AwardedSpainGoods
SUMINISTRO MEDICAMENTOS EXCLUSIVOS: SEBELIPASA ALFA (KANUMA) Y RAVULIZUMAB (ULTOMIRIS).
- Published
- Published 13 January 2026
Overview
SUMINISTRO MEDICAMENTOS EXCLUSIVOS: SEBELIPASA ALFA (KANUMA) Y RAVULIZUMAB (ULTOMIRIS).
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Procedure
- Direct
- Published
- 13 January 2026
Pharmaceutical products
Award outcome
- Awarded value
- €447,017
- Award date
- 28 November 2025
- Contract period
- — → 23 November 2026
- Alexion Pharma Spain, S.L.U.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
13 January 2026
Contracting authority
Servicio Madrileno de Salud, Hospital Universitario La Paz
Procuring entityMadrid, Spain
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.